Status:
COMPLETED
Effects of Glutamine on GLP-1 and Insulin Secretion in Man
Lead Sponsor:
Garvan Institute of Medical Research
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
This study investigated the effect of glutamine, an amino acid, glycemia, glucagon-like peptide-1 (GLP-1) and insulin in participants with type 2 diabetes.
Detailed Description
In this study, we investigated the effect of glutamine, an amino acid, on glycemia and on GLP-1 and insulin in participants with type 2 diabetes. Preliminary data published by our group suggests that ...
Eligibility Criteria
Inclusion
- Type 2 diabetes, on metformin or diet alone (not sulphonylureas or insulin)
Exclusion
- Malabsorption, renal or liver disease, treatment with steroids
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00673894
Start Date
April 1 2008
End Date
November 1 2014
Last Update
May 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Facility
Sydney, New South Wales, Australia, 2010